|
HY-134903-10mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-100mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-25mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-5mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-50mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0346A-10mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0346A-25mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0346A-5mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-10mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-25mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-5mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-50mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-109785A-1mg
|
MedChemexpress LLC
|
(R)-Gyramide A (hydrochloride) [CAS 1793050-70-0]
|
|
|
|
|
HY-N1356A-1mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-N1356A-5mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-13212-10mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13212-5mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13212-1mL
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1738-1mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1738-10mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1738-5mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N7813-25mg
|
MedChemexpress LLC
|
1,2-Dipalmitoyl-3-oleoylglycerol [CAS 1867-91-0]
|
|
|
|
|
HY-144016-10mg
|
MedChemexpress LLC
|
16:0 EPC (chloride) [CAS 328250-18-6]
|
|
|
|
